Paras Health Udaipur Highlights Rising Clinical Demand for Radiation in Non-Oncological Treatments at High-Level CME

Udaipur | Paras Health Udaipur, through its Onco-Sciences Department, hosted a high-impact academic Continuing Medical Education (CME) session focusing on the growing role of radiation therapy in non-oncological indications. Senior specialists were invited to share the latest clinical evidence, case experiences, and treatment outcomes. The scientific discussion emphasized how precision radiotherapy—traditionally associated with cancer care—is now emerging as a game-changing option for patients suffering from complex benign and functional disorders who do not respond adequately to standard therapies.

The CME explored the expanding applications of radiation therapy in conditions such as Trigeminal Neuralgia, Keloids, Heterotopic Ossification, functional disorders, and certain inflammatory diseases, thereby offering improved treatment avenues for patients with limited alternatives.

Speaking at the event, Dr. Kirti Shivhari, Radiation Oncologist at Paras Health Udaipur, said:
“This reflects a significant shift in how we view radiotherapy. Beyond advanced cancer care, we are now using precision radiation to relieve painful conditions, prevent recurrence, and improve daily functioning in non-oncological patients. For many, such precision therapy can be life-changing where traditional treatments offer limited benefit.”

Recent institutional studies from leading Indian tertiary centers reinforce this positive trend. Long-term audits reveal that immediate postoperative radiotherapy after keloid excision significantly reduces recurrence, while studies also indicate functional improvement in heterotopic ossification when adjuvant radiation is included in treatment. Indian dosimetric research confirms that stereotactic radiosurgery platforms such as Gamma Knife, CyberKnife, and LINAC-based systems deliver high precision while protecting healthy tissue—supporting their increasing use for pain control and functional preservation in non-oncological settings.

Emphasizing evidence-based multidisciplinary decision-making, Director of Medical Oncology, Dr. Manoj Mahajan, stated:
“Radiation in non-oncological cases should never be viewed as a quick standalone solution. Best results emerge when decisions are driven by robust clinical evidence, combined expertise, and personalized evaluation. Team-based planning ensures radiation is used only where it truly enhances outcomes.”

From a surgical perspective, Dr. Saurabh Sharma, Surgical Oncologist at Paras Health Udaipur, added:
“In recurrent benign conditions such as keloids or heterotopic ossification, postoperative radiotherapy can drastically lower recurrence rates, stabilize treatment outcomes, preserve functional ability, and provide long-term relief.”

The session underscored an evolving treatment paradigm backed by clinical science, precision technology, and collaborative care, reflecting a promising future for patients beyond oncology.